Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cytomegalovirus Infection

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    January 2024
  1. GALAVERNA F, Baccelli F, Zama D, Tridello G, et al
    Letermovir for Cytomegalovirus infection in pediatric patients undergoing allogenic hematopoietic stem cell transplantation: a real-life study by the Infectious Diseases Working Group of Italian Association of Pediatric Hematology-Oncology (AIEOP).
    Bone Marrow Transplant. 2024 Jan 25. doi: 10.1038/s41409-024-02209.
    PubMed     Abstract available


  2. BASHEY SZ, Solomon SR, Zhang X, Morris LE, et al
    Letermovir prophylaxis lowers the incidence of Non-CMV infections after allogeneic hematopoietic cell transplantation.
    Bone Marrow Transplant. 2024 Jan 23. doi: 10.1038/s41409-024-02201.
    PubMed    


    November 2023
  3. MALAGOLA M, Radici V, Farina M, Pellizzeri S, et al
    Correction: CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2023 Nov 29. doi: 10.1038/s41409-023-02158.
    PubMed    


    October 2023
  4. MALAGOLA M, Radici V, Farina M, Pellizzeri S, et al
    CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2023 Oct 19. doi: 10.1038/s41409-023-02124.
    PubMed    


  5. OROFINO G, Xue E, Doglio M, Noviello M, et al
    Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir.
    Bone Marrow Transplant. 2023;58:1104-1111.
    PubMed     Abstract available


    August 2023
  6. KABUT T, Weinbergerova B, Folber F, Lengerova M, et al
    High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience.
    Bone Marrow Transplant. 2023 Aug 23. doi: 10.1038/s41409-023-02081.
    PubMed     Abstract available


  7. PRUITT A, Gao F, De Togni E, Cochran H, et al
    Impact of donor age and relationship on outcomes of peripheral blood haploidentical hematopoietic cell transplantation.
    Bone Marrow Transplant. 2023;58:855-862.
    PubMed     Abstract available


    March 2023
  8. EBERHARDT KA, Jung V, Knops E, Heger E, et al
    CMV-IgG pre-allogeneic hematopoietic stem cell transplantation and the risk for CMV reactivation and mortality.
    Bone Marrow Transplant. 2023 Mar 3. doi: 10.1038/s41409-023-01944.
    PubMed     Abstract available


    January 2023
  9. PERCHETTI GA, Biernacki MA, Xie H, Castor J, et al
    Cytomegalovirus breakthrough and resistance during letermovir prophylaxis.
    Bone Marrow Transplant. 2023 Jan 24. doi: 10.1038/s41409-023-01920.
    PubMed     Abstract available


    December 2022
  10. SUN X, Fu H, Wang C, Zhang Y, et al
    Predicting the loss of hepatitis B surface antigen following haematopoietic stem cell transplantation in patients with chronic HBV infection.
    Bone Marrow Transplant. 2022 Dec 1. doi: 10.1038/s41409-022-01880.
    PubMed     Abstract available


    November 2022
  11. CESARO S, Ljungman P, Tridello G, Mikulska M, et al
    New trends in the management of cytomegalovirus infection after allogeneic hematopoietic cell transplantation: a survey of the Infectiois Diseases Working Pary of EBMT.
    Bone Marrow Transplant. 2022 Nov 17. pii: 10.1038/s41409-022-01863.
    PubMed     Abstract available


  12. SOLH MM, Farnham C, Solomon SR, Bashey A, et al
    Extracorporeal photopheresis (ECP) improves overall survival in the treatment of steroid refractory acute graft-versus-host disease (SR aGvHD).
    Bone Marrow Transplant. 2022 Nov 9. pii: 10.1038/s41409-022-01860.
    PubMed     Abstract available


    October 2022
  13. GOKARN A, Shenoy R, Punatar S, Mirgh S, et al
    Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants.
    Bone Marrow Transplant. 2022 Oct 30. pii: 10.1038/s41409-022-01850.
    PubMed    


    February 2022
  14. BASILIO-QUEIROS D, Venturini L, Luther-Wolf S, Dammann E, et al
    Adaptive NK cells undergo a dynamic modulation in response to human cytomegalovirus and recruit T cells in in vitro migration assays.
    Bone Marrow Transplant. 2022 Feb 17. pii: 10.1038/s41409-022-01603.
    PubMed     Abstract available


    November 2021
  15. GARNICA M, Dalcolmo S, Gaio B, de Almeida AR, et al
    Pre-engraftment Cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation and its impact on engraftment.
    Bone Marrow Transplant. 2021 Nov 1. pii: 10.1038/s41409-021-01520.
    PubMed    


    October 2021
  16. WANG X, Yu U, Yang C, Wang C, et al
    Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Oct 20. pii: 10.1038/s41409-021-01499.
    PubMed    


    July 2021
  17. KANG HM, Kim SK, Ryu IH, Lee JW, et al
    Clinical characteristics and viral load patterns in children with cytomegalovirus gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Jul 17. pii: 10.1038/s41409-021-01394.
    PubMed     Abstract available


    May 2021
  18. KUZICH JA, Kankanige Y, Guinto J, Ryland G, et al
    T cell receptor beta locus sequencing early post-allogeneic stem cell transplant identifies patients at risk of initial and recurrent cytomegalovirus infection.
    Bone Marrow Transplant. 2021 May 24. pii: 10.1038/s41409-021-01354.
    PubMed     Abstract available


  19. STYCZYNSKI J, Tridello G, Xhaard A, Medinger M, et al
    Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.
    Bone Marrow Transplant. 2021;56:1171-1179.
    PubMed     Abstract available


    January 2021
  20. YOKOYAMA H, Kanda J, Kawahara Y, Uchida N, et al
    Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.
    Bone Marrow Transplant. 2021 Jan 8. pii: 10.1038/s41409-020-01203.
    PubMed     Abstract available


    December 2020
  21. BEAUVAIS D, Drumez E, Blaise D, Peffault de Latour R, et al
    Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.
    Bone Marrow Transplant. 2020 Dec 18. pii: 10.1038/s41409-020-01178.
    PubMed     Abstract available


  22. SOLANO C, Vazquez L, Gimenez E, de la Camara R, et al
    Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01157.
    PubMed     Abstract available


  23. MORI T, Kikuchi T, Koh M, Koda Y, et al
    Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening.
    Bone Marrow Transplant. 2020 Dec 12. pii: 10.1038/s41409-020-01176.
    PubMed     Abstract available


    November 2020
  24. MORI Y, Jinnouchi F, Takenaka K, Aoki T, et al
    Efficacy of prophylactic letermovir for cytomegalovirus reactivation in hematopoietic cell transplantation: a multicenter real-world data.
    Bone Marrow Transplant. 2020 Nov 2. pii: 10.1038/s41409-020-01082.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.